<DOC>
	<DOCNO>NCT01651182</DOCNO>
	<brief_summary>Tranexamic acid ( TXA ) antifibrinolytic agent show reduce blood loss blood transfusion requirement follow patient population : multisystem trauma , liver transplantation , cardiac surgery spine surgery . Patients undergo major liver resection risk severe perioperative blood loss may also benefit perioperative TXA administration . This open label , non-randomized study evaluate pharmacokinetic pharmacodynamic property two well studied dose regimen TXA provide guidance determine optimal TXA dose regimen patient undergo major liver resection . Compelling evidence effectiveness TXA come large multicentred , multi-national CRASH-2 trial TXA administer 1 g bolus + 1 g infusion 8 hour . In liver transplant surgery , follow dose regimen show great effect:10 mg/kg/h start surgery 2 hour reperfusion liver transplant . Although TXA currently approve use patient undergo major liver resection , Health Canada allow use tranexamic acid use research study .</brief_summary>
	<brief_title>Tranexamic Acid Versus Placebo Blood Reduce Perioperative Bleeding Post-liver Resection</brief_title>
	<detailed_description />
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Inclusion Criteria Patient undergo anticipated open laparoscopic major liver resection ( &gt; 2 hepatic segment ) , assess operating surgeon Age â‰¥ 18 year . Exclusion Criteria Previously enrol study Platelet count le 100,000/mm3 Severe anemia ( hemoglobin level less 90 g/l ) Documented arterial venous thrombosis screen past three month Anticoagulants ( LMWH heparin prophylactic dos prevent deep vein thrombosis ) , direct thrombin inhibitor thrombolytic therapy administer complete within last week Hepatectomy associate plan vascular biliary reconstruction Known disseminate intravascular coagulation Severe renal insufficiency ( CrCl &lt; 30 ) History seizure disorder Pregnant lactating Hypersensitivity tranexamic acid ingredient Unable receive blood product ( i.e . difficulty cross matching , refuse blood transfusion , past history unexplained severe transfusion reaction ) Receipt chemotherapy within 4 week schedule operation Patients undergoing resection live donor liver transplant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Blood transfusion</keyword>
	<keyword>Blood loss</keyword>
	<keyword>Postoperative complication</keyword>
	<keyword>Outcome</keyword>
</DOC>